nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentagastrin—CCKBR—connective tissue—skin cancer	0.104	0.328	CbGeAlD
Pentagastrin—CCKBR—Peptide GPCRs—MC1R—skin cancer	0.0952	0.139	CbGpPWpGaD
Pentagastrin—CCKBR—female reproductive system—skin cancer	0.0733	0.231	CbGeAlD
Pentagastrin—CCKBR—head—skin cancer	0.0612	0.193	CbGeAlD
Pentagastrin—CCKBR—GPCRs, Other—SMO—skin cancer	0.0545	0.0798	CbGpPWpGaD
Pentagastrin—CCKBR—Peptide ligand-binding receptors—MC1R—skin cancer	0.0448	0.0656	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Class A Rhodopsin-like—MC1R—skin cancer	0.0351	0.0513	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—PTCH2—skin cancer	0.0316	0.0463	CbGpPWpGaD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—MC1R—skin cancer	0.03	0.044	CbGpPWpGaD
Pentagastrin—BCHE—Peptide hormone metabolism—EXOC2—skin cancer	0.0292	0.0428	CbGpPWpGaD
Pentagastrin—CCKBR—GPCRs, Class A Rhodopsin-like—PTGER4—skin cancer	0.0231	0.0337	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—MC1R—skin cancer	0.0229	0.0335	CbGpPWpGaD
Pentagastrin—BCHE—nipple—skin cancer	0.0228	0.072	CbGeAlD
Pentagastrin—CCKBR—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	0.0198	0.0289	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—RHOU—skin cancer	0.0196	0.0287	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—SHH—skin cancer	0.0163	0.0239	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—PTCH2—skin cancer	0.0162	0.0238	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—PTCH1—skin cancer	0.0155	0.0226	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—SMO—skin cancer	0.0155	0.0226	CbGpPWpGaD
Pentagastrin—CCKBR—GPCR ligand binding—PTGER4—skin cancer	0.015	0.022	CbGpPWpGaD
Pentagastrin—BCHE—skin of body—skin cancer	0.0146	0.0461	CbGeAlD
Pentagastrin—BCHE—mammalian vulva—skin cancer	0.0133	0.042	CbGeAlD
Pentagastrin—CCKBR—GPCR downstream signaling—MC1R—skin cancer	0.0129	0.0189	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—MC1R—skin cancer	0.0117	0.0172	CbGpPWpGaD
Pentagastrin—BCHE—female reproductive system—skin cancer	0.0114	0.036	CbGeAlD
Pentagastrin—CCKBR—Signaling Pathways—PTCH2—skin cancer	0.00959	0.014	CbGpPWpGaD
Pentagastrin—BCHE—head—skin cancer	0.00953	0.0301	CbGeAlD
Pentagastrin—CCKBR—GPCR downstream signaling—PTGER4—skin cancer	0.0085	0.0124	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—SHH—skin cancer	0.00836	0.0122	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—PTCH1—skin cancer	0.00793	0.0116	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—SMO—skin cancer	0.00793	0.0116	CbGpPWpGaD
Pentagastrin—CCKBR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—skin cancer	0.00783	0.0115	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—PTGER4—skin cancer	0.00772	0.0113	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—GLI2—skin cancer	0.00727	0.0106	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—MC1R—skin cancer	0.00693	0.0102	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—GLI1—skin cancer	0.00683	0.01	CbGpPWpGaD
Pentagastrin—CCKBR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	0.00674	0.00987	CbGpPWpGaD
Pentagastrin—BCHE—lymph node—skin cancer	0.00667	0.0211	CbGeAlD
Pentagastrin—CCKBR—Signaling Pathways—SUFU—skin cancer	0.00648	0.00948	CbGpPWpGaD
Pentagastrin—CCKBR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	0.00573	0.00839	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of proteins—EXOC2—skin cancer	0.00552	0.00808	CbGpPWpGaD
Pentagastrin—CCKBR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	0.00548	0.00803	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	0.00511	0.00747	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—SHH—skin cancer	0.00494	0.00723	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—RASA1—skin cancer	0.00491	0.00719	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—SMO—skin cancer	0.00468	0.00686	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—PTCH1—skin cancer	0.00468	0.00686	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—PTGER4—skin cancer	0.00456	0.00667	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—FOXO4—skin cancer	0.00403	0.0059	CbGpPWpGaD
Pentagastrin—BCHE—Transmission across Chemical Synapses—BRAF—skin cancer	0.00278	0.00408	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—TERT—skin cancer	0.00269	0.00394	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—PLIN2—skin cancer	0.00227	0.00333	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—NRAS—skin cancer	0.00227	0.00332	CbGpPWpGaD
Pentagastrin—BCHE—Neuronal System—BRAF—skin cancer	0.00213	0.00312	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—BRAF—skin cancer	0.00213	0.00312	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—KRAS—skin cancer	0.00195	0.00286	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—CSPG4—skin cancer	0.00183	0.00268	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—HRAS—skin cancer	0.00166	0.00243	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling by GPCR—IL6—skin cancer	0.00159	0.00232	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—NRAS—skin cancer	0.00134	0.00196	CbGpPWpGaD
Pentagastrin—BCHE—Transmission across Chemical Synapses—HRAS—skin cancer	0.00128	0.00187	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—ENO2—skin cancer	0.00125	0.00182	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—KRAS—skin cancer	0.00115	0.00169	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—TP53—skin cancer	0.00102	0.0015	CbGpPWpGaD
Pentagastrin—BCHE—Neuronal System—HRAS—skin cancer	0.000981	0.00144	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—HRAS—skin cancer	0.00098	0.00143	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	0.000974	0.00143	CbGpPWpGaD
Pentagastrin—CCKBR—Signaling Pathways—IL6—skin cancer	0.000938	0.00137	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—ERCC2—skin cancer	0.000724	0.00106	CbGpPWpGaD
Pentagastrin—BCHE—Metabolism—PTGS2—skin cancer	0.000434	0.000635	CbGpPWpGaD
